Estimates Revisions Vertex Pharmaceuticals Incorporated Sao Paulo
Stocks
VRTX34
BRVRTXBDR001
Pharmaceuticals
|
Market Closed -
Sao Paulo
03:29:53 2026-09-29 pm EDT
|
5-day change | 1st Jan Change | ||
| 85.86 BRL | -0.42% |
|
+3.50% | +9.74% |
| Sep. 28 | UBS Raises Vertex Pharmaceuticals Price Target to $615 From $585, Maintains Buy Rating | MT |
| Sep. 23 | TD Cowen Adjusts PT on Vertex Pharmaceuticals to $550 From $525, Maintains Buy Rating | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Vertex Pharmaceuticals Incorporated(VRTX)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Vertex Pharmaceuticals Incorporated(VRTX)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Vertex Pharmaceuticals Incorporated(VRTX)
EBIT
Dividend / Share (DPS)
Data source:
Vertex Pharmaceuticals Incorporated(VRTX)
Cash or Net Debt
Select your edition
All financial news and data tailored to specific country editions
